Genolution Inc. (KOSDAQ:225220)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Biotechnology	7.14B	9.76B	38.08B
Biotechnology Growth	-26.90%	-74.37%	-
Total	7.14B	9.76B	38.08B
Total Growth	-26.90%	-74.37%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
South Korea	7.14B	9.76B	38.08B
South Korea Growth	-26.90%	-74.37%	-
Total	7.14B	9.76B	38.08B
Total Growth	-26.90%	-74.37%	-

Source: S&P Global Market Intelligence.